Migratory functions of natural killer cells

Natural Immunity

Volumn 15, Issue 2-3, 1997, Pages 117-133

  Somersalo, Kristina ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adhesion receptor; Chemotaxis; Haptotaxis; Migration; Natural killer cell

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; FIBRONECTIN; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 2; MATRIX PROTEIN; SELECTIN;

ARTICLE; CELL ADHESION; CHEMOKINESIS; CHEMOTAXIS; ENDOTHELIUM CELL; LYMPHOCYTE MIGRATION; NATURAL KILLER CELL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL MOVEMENT; HUMANS; KILLER CELLS, NATURAL;

EID: 8044228389     PISSN: 10188916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (170)

1. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101.
2. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigraton: The multistep paradigm. Cell 1994;76:301-314.
3. Hamann A: Mechanisms of lymphocyte traffic and cell targeting. Int J Cancer Suppl 1992;7:19-23.
4. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
5. Lasky LA: Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258:964-969.
6. Lawrence MB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-873.
7. Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell 1990;62:3-6.
8. Pinola M, Renkonen R, Majuri M-L, Tiisala S, Saksela E: Characterization of the E-selectin ligand on NK cells. J Immunol 1994;152:3586-3594.
9. Koopman G, van Kooyk Y, de Graaff M, Meyer CJLM, Figdor CG, Pals ST: Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol 1990;145: 3589-3593.
10. Dustin ML, Springer TA: T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989;341:619-624.
11. Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S: CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J Exp Med 1992; 176:245-253.
12. Dransfield I, Cabanas C, Craig A, Hogg N: Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992;116: 219-226.
13. Shimizu Y, Mobley JL: Distinct divalent cation requirements for integrin-mediated CD4+ T lymphocyte adhesion to ICAM-1, fibronectin, VCAM-1 and invasin. J Immunol 1993;151:4106-4115..
14. Hermanowski-Vosatka A, Van Strijp JAG, Swiggard WJ, Wright SD: Integrin modulating factor-1: A lipid that alters the function of leukocyte integrins. Cell 1992;68:341-352.
15. Rot A: Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration. Immunol Today 1992;13: 291-294.
16. Shimizu Y, Newman W, Tanaka Y, Shaw S: Lymphocyte interactions with endothelial cells. Immunol Today 1992;13:106-112.
17. Beekhuizen H, Blokland I, van Furth R: Cross-linking of CD14 molecules on monocytes results in a CD11/CD18- and ICAM-1-dependent adherence to cytokine-stimulated human endothelial cells. J Immunol 1993;150:950-959.
18. Campanero MR, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Hernandez-Caselles T, Craig A, Pulido R, Sanchez-Madrid F: ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 1993;123:1007-1061.
19. Campanero MR, Sanchez-Mateos P, del Pozo MA, Sanchez-Madrid F: ICAM-3 regulates lymphocyte morphology and integrin mediated T cell interaction with endothelial cell and extracellular matrix ligands. J Cell Biol 1994;127:867-878.
20. Lo SK, Lee S, Ramos RA, Loob R, Rosa M, Chi-Rosso G, Wright SD: Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, αmβ2) on human neutrophils. J Exp Med 1991;173:1493-1500.
21. Li R, Xie J, Kantor C, Koistinen V, Altieri D, Nortamo P, Gahmberg CG: A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/ CD18. J Cell Biol, in press.
22. Lee, DHS, MacIntyre JP, Wang E, Hudson DJ, Ishaque A, Conant JA, Pope BL, Lau CY: A leukocyte lipid up-regulates the avidity of lymphocyte function-associated antigen-1. Biochem Biophys Res Commun 1994;199:319-326.
23. Keizer GD, Visser W, Vliem M, Figdor CG: A monoclonal antibody (NKI-L16) directed against a unique epitope on the alfa-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J Immunol 1988;140: 1393-1400.
24. Landis RC, Bennett RI, Hogg N: A novel LFA-1 activation epitope maps to the I domain. J Cell Biol 1993;120:1519-1527.
25. Kornberg L, Juliano RL: Signal transduction from the extracellular matrix: The integrin-tyrosine kinase connection. Trends Pharmacol Sci 1992;13:93-95.
26. Symington BE, Takada Y, Carter WG: Interaction of integrins α3β1 and α2β1: Potential role in keratinocyte intercellular adhesion. J Cell Biol 1993;120:523-535.
27. Larjava H, Peltonen J, Akiyama SK, Yamada SS, Gralnick HR, Uitto J, Yamada KM: Novel function for β1 integrins in keratinocyte cell-cell interactions. J Cell Biol 1990;110: 803-815.
28. Carter WG, Wayner EA, Bouchard TS, Kaur P: The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 1990;110: 1387-1404.
29. Isberg RR, Leong JM: Multiple β1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990;60:861-871.
30. Leong JM, Fournier RS, Isberg RR: Identification of the integrin-binding domain of the Yersinia pseudotuberculosis invasin protein. EMBO J 1990;9:1979-1989.
31. Bianchi G, Sironi M, Ghibaudi E, Selvaggini C, Elices M, Allavena P, Mantovani A: Migration of natural killer cells across endothelial cell monolayers. J Immunol 1993;151: 5135-5144.
32. Kitayama J, Juji T, Atomi Y, Kuroda A, Muto T, Kobayashi M, Mitsui Y, Minami M: Transendothelial migration activity of lymphokine-activated killer (LAK) cells. J Immunol 193;151:1663-1672.
33. Oppenheimer-Marks N, Davis LS, Lipsky PE: Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J Immunol 1990;145:140-148.
34. Carpén O, Dustin ML, Springer TA, Swafford JA, Beckett LA, Caulfield JP: Motility and ultrastructure of large granular lymphocytes on lipid bilayers reconstituted with adhesion receptors LFA-1, ICAM-1 and two isoforms of LFA-3. J Cell Biol 1991; 115:861-871.
35. Jääskeläinen J, Mäenpää A, Patarroyo M, Gahmberg CG, Somersalo K, Tarkkanen J, Kallio M, Timonen T: Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved. J Immunol 1992;149:260-268.
36. Springer TA, Dustin ML, Kishimoto TK, Marlin SD: The lymphocyte function-associated LFA-1, CD2 and LFA-3 molecules: Cell adhesion receptors of the immune system. Annu Rev Immunol 1987;5:223-252.
37. Timonen T, Gahmberg CG, Patarroyo M: Participation of CD11a-c/ CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes. Int J Cancer 1990;46: 1035-1040.
38. Somersalo K, Tarkkanen J, Patarroyo M, Saksela E: Involvement of beta-2 integrins in the migration of human natural killer cells. J Immunol 1992;149:590-598.
39. Ramos OF, Patarroyo M, Yefenof E, Klein E: Requirement of leukocytic cell adhesion molecules CD11a-c/ CD18 in the enhanced NK lysis of iC3b-opsonized targets. J Immunol 1989;142:4100-4104.
40. Allavena P, Paganin C, Martin-Padura I, Peri G, Gaboli M, Dejana E, Marchisio PC, Mantovani A: Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J Exp Med 1991;173:439-448.
41. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I: Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994;179: 1145-1154.
42. Issekuts TB: Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A liklely role for VLA-4 in vivo. J Immunol 1991;147:4178-4184.
43. Berg EI, McEvoy LM, Berlin C, Bargatze RF, Butcher EC: L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993;366: 695-698.
44. Timonen T, Patarroyo M, Gahmberg CG: CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J Immunol 1988;141:1041-1046.
45. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunen D, Imhof BA: CD31/PECAM-1 is a ligand for a Vβ3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995;130:451-460.
46. Bird IN, Spragg JH, Ager A, Matthews N: Studies of lymphocyte transendothelial migration: Analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 1993;80:553-560.
47. Bogen S, Pak J, Garifallou M, Deng X, Muller WA: Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 1994;179:1059-1064.
48. Vaporciyan AA, DeLisser HM, Yan H-C, Mendiguren II, Thom SR, Jones ML, Ward PA, Albelda SM: Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993;262:1580-1582.
49. Butcher EC: Cellular and molecular mechanisms that direct leukocyte traffic. Am J Pathol 1990;136:3-12.
50. Carter WG, Wayner EA: Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 1988;263:4193-4201.
51. Jalkanen S, Reichert RA, Gallatin WM, Bargatze RF, Weissman IL, Butcher EC: Homing receptors and the control of lymphocyte migration. Immunol Rev 1986;91:39-60.
52. Dujivestijn A, Hamann A: Mechanisms and regulation of lymphocyte migration. Immunol Today 1989; 10:23-28.
53. Salmi M, Jalkanen S: A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992;257:1407-1409.
54. Airas L, Salmi M, Jalkanen S: Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J Immunol 1993;151: 4228-4238.
55. Airas L, Hellman J, Salmi M, Bono P, Puurunen T, Smith DJ, Jalkanen S: CD73 is involved in lymphocyte binding to the endothelium: Characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med 1995;182:1603-1608.
56. Salmi M, Kalimo K, Jalkanen S: Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med 1993;178:2255-2260.
57. Caterina MJ, Devreotes PN: Molecular insights into eukaryotic chemotaxis. FASEB J. 1991;5:3078-3085.
58. Devreotes PN, Zigmond SH: Chemotaxis in eukaryotic cells: A focus on leukocytes and dictyostelium. Annu Rev Cell Biol 1988;4:649-686.
59. Polentarutti N, Bottazzi B, Balotta C, Erroi A, Mantovani A: Modulation of the locomotory capacity of human large granular lymphocytes. Cell Immunol 1986;101:204-212.
60. Punturieri A, Santoni A, Ming JW, Nobili N, Matovani A, Bottazzi B: In vitro migration of rat large granular lymphcoytes. Cell Immunol 1989;123:257-263.
61. Bottazzi B, Introna M, Allavena P, Villa A, Mantovani A: In vitro migration of human large granular lymphocytes. J Immunol 1985;134: 2316-2321.
62. Zimmerman GA, Prescott SM, McIntyre TM: Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 1992;13:93-100.
63. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
64. Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ: Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989;264:7768-7771.
65. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B: Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243:1160-1165.
66. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 1990;50:537-544.
67. Luscinskas FW, Cybulsky MI, Kiely J-M, Peckins CS, Davis VM, Gimbrone MA Jr: Cytokine-activated human endothelial monolayers suport enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 1991; 146:1617-1625.
68. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM: An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-a increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol 1986;136:4548-4553.
69. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R: Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-1211.
70. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986;137: 1893-1896.
71. Moore KL, Thompson LF: P-selectin (CD62) binds to subpopulations of human memory T lymphocytes and natural killer cells. Biochem Biophys Res Commun 1992; 186:173-181.
72. Ohmori K, Yoneda T, Ishihara G, Shigeta K, Hirashima K, Kanai M, Itai S, Sasaoki T, Arii S, Arita H, Kannagi R: Sialyl SSEA-1 antigen as a carbohydrate marker of human natural killer cells and immature lymphoid cells. Blood 1989;74:255-261.
73. Munro MJ, Lo SK, Corless C, Robertson MJ, Lee NC, Barnhill RL, Weinberg DS, Bevilacqua MP: Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol 1992;141:1397-1408.
74. Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MAJ, Tedder TF: Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991;147:2556-2573.
75. Mäenpää A, Jääskeläinen J, Carpén O, Patarroyo M, Timonen T: Expression of integrins and the other adhesion molecules on NK cells; impact of IL-2 on short and long-term cultures. Int J Cancer 1993;53:850-855.
76. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC: α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-422.
77. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA: The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995;128:1243-1253.
78. Shimizu Y, Newman W, Gopal TV, Horgan KJ, Graber N, Beall LD, van Seventer GA, Shaw S: Four molecular pathways of T cell adhesion to endothelial cells: Roles of LFA-1, VAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditons. J Cell Biol 1991;113:1203-1212.
79. Elices MJ, Tsai V, Strahl D, Goel AS, Tollefson V, Arrhenius T, Wayner EA, Caeta F, Fikes JD, Firestein GS: Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 1994;93:405-416.
80. Jones DA, McIntire LV, Smith CW, Picker LJ: A two-step adhesion cascade for T cell/endothelial cell interactions under flow conditions. J Clin Invest 1994;94:2443-2450.
81. Oppenheimer-Marks N, Davis LS, Bogue DT, Ramberg J, Lipsky PE: Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991;147:2913-2921.
82. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA: ICAM-1 (CD54): A counter-receptorfor Mac-1 (CD11b/CD18). J Cell Biol 1990;111:3129-3139.
83. Languino LR, Plescia J, Duperray A, Brain AA, Plow EF, Geltosky JE, Altieri DC: Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993;73: 1423-1434.
84. Zocchi MR, Poggi A: NCAM and lymphocyte adhesion in leukocyte adhesion deficiency (LAD) syndrome. Immunol Today 1993;14: 94-95.
85. Martin GR, Timpl R: Laminin and other basement membrane components. Annu Rev Cell Biol 1987;3: 57-85.
86. Farquhar MG: The glomerular basement membrane: A selective macromolecular filter; in Hay ED (ed): Cell Biology of Extracellular Matrix. New York, 1981, pp 335-378.
87. Ruoslahti E: Fibronectin and its receptors. Annu Rev Biochem 1988; 57:375-413.
88. Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM: Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Cell Biol 1988;106:6886-6892.
89. Ratner S: Lymphocyte migration through extracellular matrix. Invasion Metastasis 1992;12:82-100.
90. Somersalo K, Saksela E: Fibronectin facilitates the migration of human natural killer cells. Eur J Immunol 1991;21:35-42.
91. Somersalo K: Migration, and Associated Immunoregulatory Functions of Human Natural Killer Cells; thesis University of Helsinki, 1995.
92. Hemler ME: VLA proteins in the integrin family: Structures, functions, and their role on leukocytes. Annu Rev Immunol 1990;8:365-400.
93. Saltini C, Hemler ME, Crystal RG: T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. Clin Immunol Immunopathol 1988;46:221-233.
94. Hemler ME, Glass D, Coblyn JS, Jacobson JG: Very late activation antigens on rheumatoid synovial fluid T lymphocytes: Association with stages of T cell activation. J Clin Invest 1986;78:696-702.
95. Shimizu Y, Van Seventer GA, Horgan KJ, Shaw S: Regulated expression and binding of three VBLA (beta 1) integrin receptors on T cells. Nature 1990;345:250-253.
96. Morrone S, Gismondi A, Mainiero F, Milella M, Santoni G, Falcioni R, Piccoli M, Frati L, Santoni A: Expression of betal integrin laminin receptors by fresh and cultured human NK cells. Seventh International Workshop on Natural Killer cells. Nat Immun 1991;10:135.
97. Savino W, Villa-Verde DMS, Lannes Vieira J: Extracellular matrix proteins in intrathymic T-cell migration and differentiation? Immunol Today 1993;14:158-161.
98. Shimizu Y, Shaw S: Lymphocyte interactions with extracellular matrix. FASEB J 1991;5:2292-2299.
99. Pirelli A, Allavena P, Mantovani A: Activated adherent large granular lymphocytes/natural killer (LGL/NK) cells change their migratory behaviour. Immunology 1988;65:651-655.
100. Figdor CG, van Kooyk Y, Keizer GD: On the mode of action of LFA-1. Immunol Today 1990;11: 277-280.
101. Li R, Nortamo P, Kantor C, Kovanen P, Timonen T, Gahmberg CG: A leukocyte integrin binding peptide from intercellular adhesion molecule-2 stimulates T cell adhesion and natural killer cell activity. J Biol Chem 1993;268: 21474-21477.
102. Somersalo K, Carpén O, Saksela E, Nortamo P, Gahmberg CG, Timonen T: Activation of NK cell migration by leukocyte binding peptide from ICAM-2. J Biol Chem 1995;270:8629-8636.
103. Nortamo P, Li R, Renkonen R, Timonen T, Prieto J, Patarroyo M, Gahmberg CG: The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol 1991;21:2629-2632.
104. Gorski A: The role of cell adhesion molecules in immunopathology. Imunol Today 1994;15:251-255.
105. Carter SB: Principles of cell motility: The direction of cell movement and cancer invasion. Nature 1965; 5016:1183-1187.
106. Harvath L: Regulation of neutrophil chemotaxis: Correlations with actin polymerization. Cancer Invest 1990;8:651-654.
107. del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F: Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol 1995;131:495-508.
108. Perez HD, Elfman F, Lobo E, Sklar L, Chenoweth D, Hooper C: A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors. J Immunol 1986;136:1803-1812.
109. Samanta AK, Oppenheim JJ, Matsushima K: Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 1990; 265:183-189.
110. Fehr J, Dahinden C: The modulating influence of chemotactic factor-induced cell adhesiveness upon granuloyte (PMN) function (abstract). Clin Res 1978;26:346a.
111. Sullivan SJ, Zigmond SH: Chemotactic peptide receptor modulation in polymorphonuclear leukocytes. J Cell Biol 1980;85:703-711.
112. Hunninghake GW, Glazier AJ, Monick MM, Dinarello CA: Interleukin 1 is a chemotactic factor for human T-lymphocytes. Am Rev Respir Dis 1987;135:66-71.
113. Kornfeld H, Berman JS, Beer DJ, Center DM: Induction of human T lymphocyte motility by interleukin 2. J Immunol 1985;134:3887-3890.
114. Camp R, Bacon K, Fincham N, Mistry K, Ross J, Lawlor F, Quinn D, Gearing A: Chemotactic cytokines in inflammatory skin disease. Adv Exp Med Biol 1991;305: 109-118.
115. Wilkinson PC, Liew FY: Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 1995;181:1255-1259.
116. Issekutz TB, Stoltz JM: Stimulation of lymphocyte migration by endotoxin, tumor necrosis factor, and interferon. Cell Immunol 1989;120:165-173.
117. Adams DH, Hathaway M, Shaw J, Burnett D, Elias E, Strain AJ: Transforming growth factor β induces human T lymphocyte migration in vitro. J Immunol 1991;147: 609-612.
118. Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, Kornfeld H: Molecular and functional analysis of a lymphocyte chemoattractant factor: Association of biologic function with CD4 expression. Proc Natl Acad Sci 1994;91:5109-5113.
119. Center D, Cruikshank W: Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol 1982;128:2563-2568.
120. Laberge S, Cruikshank WW, Kornfiel H, Center DM: Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcripion and translation: Evidence for constitutive protein synthesis and storage. J Immunol 155;1995;2902-2910.
121. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989;243: 1464-1466.
122. Ahuja SK, Gao JL, Murphy PM: Chemokine receptors and molecular mimicry. Immunol Today 1994;15:281-287.
123. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994;91:3652-3656.
124. Keiner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A: Lymphotactin: A cytokine that represents a new class of chemokine. Science 1994;266:1395-1399.
125. Kennedy J, Keiner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, Schneider PV, Cocks BG, Bacon KB, Zlotnik A: Molecular cloning and functional characterization of human lymphotactin. J Immunol 1995;155:203-209.
126. McIntyre KW, Welsh RM: Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J Exp Med 1986;164:1667-1681.
127. Natuk RJ, Welsh RM: Accumulation and chemotaxis of natural killer/large granular lymphocyes at sites of virus replication. J Immunol 1987;138:877-883.
128. Seko Y, Yamazaki T, Shinkai Y, Yagita H, Okumura K, Naito S, Imataka K, Fujii J, Yazaki Y: Cellular and moleculer bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy. Jpn Circ J 1992;56:1062-1072.
129. Nemlander A, Saksela E, Häyry P: Are 'natural killer' cells involved in allograft rejection? Eur J Immunol 1983;13:348-350.
130. Marboe CC, Knowles DMI, Chess L, Reemtsma K, Fenoglio JJJ: The immunologic and ultrastructural characterization of the cellular infilrate in acute cardiac allograft rejection: Prevalence of cells with the natural killer (NK) phenotype. Clin Immunol Immunopathol 1983;27:141-151.
131. Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JR, Pardi R: Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992;149:1416-1423.
132. Inverardi L, Samaja M, Marelli F, Bender JR, Pardi R: Cellular early immune recognition of xenogeneic vascular endothelium. Transplant Proc 1992;24:459-461.
133. Thomas FT, Marchman W, Carobbi A, Araneda D, Pryor W, Thomas J: Immunobiology of the xenograft response: Xenograft rejection in immunodeficient animals. Transplant Proc 1991;23: 208-209.
134. Heller O, Hansson M, Kiessling R, Wigzell H: Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature 1977;270: 609-611.
135. Hanna N, Burton RC: Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J Immunol 1981;127:1754-1758.
136. Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW: Direct evidence for the role of LGL in the inhibition of experimental tumor metastasis. J Immunol 1985;134:2783-2789.
137. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975;16: 216-229.
138. Herberman RB, Nunn ME, Holden HT, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975; 16:230-239.
139. Greenberg AH, Khalil N, Pohajdak B, Talgoy M, Henkart P, Orr W: NK-leukocyte chemotactic factor (NK-LCF): A large granular lymphocyte (LGL) granule-associated chemotactic factor. J Immunol 1986;137:3224-3230.
140. Allavena P, Paganin C, Bianchi G, Zhou D, Sozzani S, Mantovani A: IL-12 is chemotactic for NK cells and stimulates their interaction with vascular endothelium. 2nd Meeting of the Society for Natural Immunity. The Natural Killer Cells and Its Interaction with Immune and Non-Immune Cells, Taormina, 1994, p 196.
141. Maghazachi AA, Al-Aoukaty A, Schall TJ: C-C chemokines induce the chemotaxis of NK and IL-2 activated NK cells. J Immunol 1994;153:4969-4977.
142. Taub DD, Sayers TJ, Carter CRD, Ortaldo JR: α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995;155:3877-3888.
143. Allevena P, Bianchi G, Zhou D, van Damme J, Jilek P, Sozzani S, Mantovani A: Induction of natural killer cell migration by monocyte chemotactic protein-1, -2, and -3. Eur J Immunol 1994;24:3233-3236.
144. Strieter RM, Kunkel SL, Showell HJ, Remic DG, Phan SH, Ward PA, Marks RM: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alfa, LPS, IL-1β. Science 1989;243: 1467-1469.
145. Zimmermann GA, McIntyre TM, Mehra M, Prescott SM: Endothelial cell-associated platelet-activating factor: A novel mechanism for signaling intercellular adhesion. J Cell Biol 1990;110:529-540.
146. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 1993;361:79-82.
147. Springer TA: Adhesion molecules in immunity and inflammation; in Clinical Aspects of Immunology. Boston, Lechman, Blackwell, 1993, vol 5, pp 199-219.
148. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of growth factor activities. Cell 1991;64: 867-869.
149. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 1993;361:79-82.
150. Needham LK, Schnaar RL: The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc Natl Acad Sci USA 1993;90:1359-1363.
151. Stephens LR, Hughes KT, Irvine RF: Pathway of phosphatidylinositol(3,4,5)-triphosphate synthesis in activated neutrophils. Nature 1991;351:33-38.
152. Dobos GJ, Norgauer J, Eberle M, Schollmeyer PJ, Traynor-Kaplan AE: C5a reduces formyl peptide-induced actin polymerization and phosphatidylinositol(3,4,5)trisphosphate formation, but not phosphatidylinositol(4,5)bisphosphate hydrolysis and superoxide production, in human neutrophils. J Immunol 1992;149:609-614.
153. Turner L, Ward SG, Westwick J: RANTES-activated human T lymphocytes: A role for phosphoinositide 3-kinase. J Immunol 1995; 155:2437-2444.
154. Chambard JC, Pouyssegur J: TGF-β inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events. J Cell Physiol 1988;135:101-107.
155. Reibman J, Meixler S, Lee TC, Gold LI, Cronstein BN, Haines KA, Kolasinski SL, Weissmann G: Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci USA 1991;88: 6805-6809.
156. Harnett M, Rigley K: The role of G-proteins versus protein tyrosine kinases in the regulation of lymphocyte activation. Immunol Today 1992;13:482-486.
157. Sastry SK, Horwitz AF: Integrin cytoplasmic domains: Mediators of cytoskeletal linkages and extra-and intracellular initiated transmembrane signaling. Curr Opin Cell Biol 1993;5:819-831.
158. Schaller MD, Parsons JT: Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 1994;6:705-710.
159. Guan JL, Trevithick JE, Hynes RO: Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul 1991;2:951-964.
160. Hanks SK, Calalb MB, Harper MC, Patel SK: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 1992;89:8487-8491.
161. Kornberg L, Earp S, Parsons JT, Schaller M, Juliano RL: Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 1992;267: 23439-23442.
162. Vuori K, Ruoslahti E: Activation of protein kinase C preceds α5β1 integrin-mediated cell spreading on fibronectin. J Biol Chem 1993; 268:21459-21462.
163. Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995;267:883-885.
164. Johansson MW, Larsson E, Lüning B, Pasquale EB, Ruoslahti E: Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated β1 integrin. J Cell Biol 1994;126:1299-1309.
165. Clark EA, Brugge JS: Integrins and signal transduction pathways. The road taken. Science 1995;268: 233-239.
166. Pardi R, Inverardi L, Rugarli C, Bender JR: Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/ CD18-cytoskeleton association in T lymphocytes. J Cell Biol 1992; 116:1211-1220.
167. Damsky CH, Werb Z: Signal transduction by integrin receptors for extracellular matrix: Cooperative processing of extracellular information. Curr Opin Cell Biol 1992; 4:772-781.
168. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM: Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995;131: 791-805.
169. Chen H-C, Guan JL: Association of focal adhesion kinase with its potential substrate phosphatidyl-inositol 3-kinase. Proc Natl Acad Sci USA 1994;91:10148-10152.
170. Schwartz MA, Ingber DE, Lawrence M, Springer TA, Lechene C: Multiple integrins share the ability to induce elevation of intracellular pH. Exp Cell Res 1991; 195:533-535.